Intended Audience
COPD treatment centers
Contract Research Organizations (CROs)
Research and Development (R&D) Companies
Government Research Laboratories
Independent Research Laboratories
Government and Independent Regulatory Authorities
Market Research and Consulting Service Providers
Medical Research Laboratories
Academic Medical Institutes and Universities
Key Players for COPD Market:
Some of the key players in this market are:
Abbott (U.S),
AstraZeneca (U.K),
GSK (U.K), F.
Hoffmann-La Roche Ltd (Switzerland),
Novartis AG (Switzerland),
Merck (U.S),
Pfizer Inc (U.S),
Dr. Reddy’s Laboratories Ltd (India).
“Ask for your specific company profile and country level customization on reports”
Segments:
Global COPD market has been segmented
On the basis of type which comprises of chronic bronchitis, emphysema.
On the basis of medicines include bronchodilators, inhaled steroids, combination inhalers, oral
steroids, phosphodiesterase-4 inhibitors, theophylline and antibiotics. Furthermore
On the basis of treatment oxygen therapy, lung transplant, bullectomy and other
Regional Analysis of COPD Market:
Globally North America is the largest market for COPD. The North American market for COPD is
expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the
forecasted period. This is due to increasing healthcare awareness in the region. Europe is the secondlargest market for COPD which is expected to grow at a CAGR of XX%. Furthermore Asia pacific market is
expected to be the growing market for COPD market.
Tel: +1-646-845-9349
[email protected]